1. Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24‐month follow‐up. Issue 7 (28th April 2014) Authors: Gambacorti‐Passerini, Carlo; Brümmendorf, Tim H.; Kim, Dong‐Wook; Turkina, Anna G.; Masszi, Tamas; Assouline, Sarit; Durrant, Simon; Kantarjian, Hagop M.; Khoury, H. Jean; Zaritskey, Andrey; Shen, Zhi‐Xiang; Jin, Jie; Vellenga, Edo; Pasquini, Ricardo; Mathews, Vikram; Cervantes, Francisco; Besson... Journal: American journal of hematology Issue: Volume 89:Issue 7(2014:Jul.) Page Start: 732 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗